These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 21989495)
1. Does the addition of clomiphene citrate or letrazole to gonadotropin treatment enhance the oocyte yield in poor responders undergoing IVF? Jovanovic VP; Kort DH; Guarnaccia MM; Sauer MV; Lobo RA J Assist Reprod Genet; 2011 Nov; 28(11):1067-72. PubMed ID: 21989495 [TBL] [Abstract][Full Text] [Related]
2. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation. Kamath MS; Maheshwari A; Bhattacharya S; Lor KY; Gibreel A Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008528. PubMed ID: 29096046 [TBL] [Abstract][Full Text] [Related]
3. The comparision of effect of microdose GnRH-a flare-up, GnRH antagonist/aromatase inhibitor letrozole and GnRH antagonist/clomiphene citrate protocols on IVF outcomes in poor responder patients. Ozcan Cenksoy P; Ficicioglu C; Kizilkale O; Suhha Bostanci M; Bakacak M; Yesiladali M; Kaspar C Gynecol Endocrinol; 2014 Jul; 30(7):485-9. PubMed ID: 24592985 [TBL] [Abstract][Full Text] [Related]
4. Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate. Ochin H; Ma X; Wang L; Li X; Song J; Meng Y; Shen J; Cui YG; Liu J J Ovarian Res; 2018 May; 11(1):37. PubMed ID: 29728130 [TBL] [Abstract][Full Text] [Related]
5. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI]. Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229 [No Abstract] [Full Text] [Related]
6. In vitro fertilization treatments with the use of clomiphene citrate or letrozole. Haas J; Casper RF Fertil Steril; 2017 Oct; 108(4):568-571. PubMed ID: 28965550 [TBL] [Abstract][Full Text] [Related]
7. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders. Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091 [TBL] [Abstract][Full Text] [Related]
8. Does the additional use of clomiphene citrate or letrozole for in vitro fertilization deserve more attention? Liang Y; Guo Q; Wu XH; Zhang LN; Ge J; Xu ML; Feng ZL; Wu XQ BMC Pregnancy Childbirth; 2021 Apr; 21(1):275. PubMed ID: 33794797 [TBL] [Abstract][Full Text] [Related]
9. Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study. Wei LH; Ma WH; Tang N; Wei JH Taiwan J Obstet Gynecol; 2016 Feb; 55(1):50-4. PubMed ID: 26927248 [TBL] [Abstract][Full Text] [Related]
11. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression. Branigan EF; Estes MA Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017 [TBL] [Abstract][Full Text] [Related]
12. Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis. Bechtejew TN; Nadai MN; Nastri CO; Martins WP Ultrasound Obstet Gynecol; 2017 Sep; 50(3):315-323. PubMed ID: 28236310 [TBL] [Abstract][Full Text] [Related]
13. Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET. Fouda UM; Sayed AM Gynecol Endocrinol; 2011 Dec; 27(12):1018-22. PubMed ID: 21714697 [TBL] [Abstract][Full Text] [Related]
14. Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders. Moffat R; Hansali C; Schoetzau A; Ahler A; Gobrecht U; Beutler S; Raggi A; Sartorius G; De Geyter C Hum Reprod; 2021 Mar; 36(4):987-997. PubMed ID: 33367742 [TBL] [Abstract][Full Text] [Related]
15. Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial. Azmoodeh A; Pejman Manesh M; Akbari Asbagh F; Ghaseminejad A; Hamzehgardeshi Z Glob J Health Sci; 2015 Sep; 8(4):244-52. PubMed ID: 26573024 [TBL] [Abstract][Full Text] [Related]
16. Minimal stimulation using gonadotropin combined with clomiphene citrate or letrozole for intrauterine insemination. Yun BH; Chon SJ; Park JH; Seo SK; Cho S; Choi YS; Kim SH; Lee BS Yonsei Med J; 2015 Mar; 56(2):490-6. PubMed ID: 25684000 [TBL] [Abstract][Full Text] [Related]
17. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization. Gibreel A; Maheshwari A; Bhattacharya S Cochrane Database Syst Rev; 2012 Nov; 11():CD008528. PubMed ID: 23152261 [TBL] [Abstract][Full Text] [Related]
18. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Jee BC; Ku SY; Suh CS; Kim KC; Lee WD; Kim SH Fertil Steril; 2006 Jun; 85(6):1774-7. PubMed ID: 16677640 [TBL] [Abstract][Full Text] [Related]
19. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797 [TBL] [Abstract][Full Text] [Related]
20. Determining the optimal follicle size at trigger in patients undergoing ovarian stimulation with a clomiphene citrate plus gonadotropin and GnRH antagonist protocol for in-vitro fertilization. Shah N; Romanski PA; Bortoletto P; Rosenwaks Z; Kligman I Minerva Obstet Gynecol; 2022 Feb; 74(1):75-82. PubMed ID: 34180612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]